# Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders

> **NCT03937661** · PHASE2,PHASE3 · RECRUITING · sponsor: **Genesis Athens Clinic** · enrollment: 100 (estimated)

## Conditions studied

- Ovary; Anomaly
- Infertility, Female

## Interventions

- **BIOLOGICAL:** PRP
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT03937661
- **Lead sponsor:** Genesis Athens Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-05-06
- **Primary completion:** 2025-01-30
- **Final completion:** 2025-08-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2024-12-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03937661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03937661, "Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03937661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*